Properly Diagnosing & Treating C. Difficile
from GI Insights
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Paul Feuerstadt, MD, FACG, AGAF In the United States, about 80 percent of tests used to diagnose C. difficile are PCR assays. So what are the best options to diagnose and treat patients with this infection? To discuss the evolving treatment and evaluation landscape for C. difficile, Dr. Peter Buch is joined by Dr. Paul Feuerstadt, Assistant Clinical Professor at Yale New Haven Hospital.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of GI Insights?
This episode is 12 minutes long.
When was this GI Insights episode published?
This episode was published on December 9, 2022.
Can I download this GI Insights episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.